The transgene consists of an SV40 promoter, Igh enhancer, and a human BCL2L1 cDNA. The Igh enhancer was used to target transgene expression to T lymphocytes. Western blot analysis verified transgene expression in the thymus. (J:30597)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count